ABVC BioPharma (ABVC) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ABVC BioPharma in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ABVC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABVC, but not buy additional shares or sell existing shares.
View ABVC analyst ratings or view top-rated stocks.

ABVC BioPharma's stock was trading at $6.25 at the start of the year. Since then, ABVC shares have decreased by 85.0% and is now trading at $0.94.
View the best growth stocks for 2023 here.

ABVC BioPharma saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 19,800 shares, a decline of 29.8% from the August 15th total of 28,200 shares. Based on an average daily trading volume, of 791,400 shares, the days-to-cover ratio is presently 0.0 days. Currently, 1.0% of the shares of the company are short sold.
View ABVC BioPharma's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our ABVC earnings forecast.

ABVC BioPharma, Inc. (NASDAQ:ABVC) issued its quarterly earnings data on Monday, August, 14th. The company reported ($0.68) EPS for the quarter. The business earned $0.01 million during the quarter. ABVC BioPharma had a negative trailing twelve-month return on equity of 477.58% and a negative net margin of 1,607.06%.

Shares of ABVC BioPharma reverse split before market open on Tuesday, July 25th 2023. The 1-10 reverse split was announced on Tuesday, July 25th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

(ABVC) raised $7 million in an initial public offering (IPO) on Tuesday, August 3rd 2021. The company issued 1,100,000 shares at $6.25 per share.

ABVC BioPharma trades on the NASDAQ under the ticker symbol "ABVC."

Shares of ABVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ABVC stock can currently be purchased for approximately $0.94.

ABVC BioPharma (NASDAQ:ABVC) has a market capitalization of $3.71 million and generates $970,000.00 in revenue each year. The company earns $-16,420,000.00 in net income (profit) each year or ($3.88) on an earnings per share basis.

ABVC BioPharma's mailing address is 44370 Old Warm Springs Boulevard, Fremont, CA 94538, United States. The official website for the company is www.abvcpharma.com. The company can be reached via phone at (510)-668-0881.